Wound care and skin restoration developer AVITA Medical (ASX: AVH) provided an update on its anticipated revenue for Q1 2024 – and has downgraded its commercial revenue guidance for the quarter. For ...
Source LinkWound care and skin restoration developer AVITA Medical (ASX: AVH) provided an update on its anticipated revenue for Q1 2024 – and has downgraded its commercial revenue guidance for the quarter. For ...
Source Link
Comments